Patterns of simultaneous polysubstance use in Canadian rave attendees

被引:98
作者
Barrett, SP
Gross, SR
Garand, I
Pihl, RO
机构
[1] McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada
[2] Natl Addict Ctr, Inst Psychiat, London, England
基金
加拿大健康研究院;
关键词
polysubstance use; rave; MDMA; amphetamine; GHB; ketamine; cocaine; substance use patterns; substance use trends;
D O I
10.1081/JA-200066866
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The aim of this study was to examine rave-related polydrug drug use and to determine if patterns of substance use were associated with previous rave attendance. One hundred and eighty-six rave attendees (50% female) representing a wide range of ages (16 to 47 years; mean = 23.5, sd = 5.15) and levels of rave attendance experience (I to 400 events) completed structured interviews in Montreal, Canada between November 2002 and September 2003 about their rave attendance patterns and their use of various licit and illicit substances at the most recently attended event. On average, participants reported using 2.5 different psychoactive substances (excluding tobacco) at the most recent event attended. Cannabis, alcohol, MDMA (ecstasy), amphetamine, cocaine, ketamine, and GHB were the most frequently reported substances, and details about their orders of administration, dosages, and patterns of co-administration are presented and discussed. The total lifetime number of raves attended by participants varied considerably (mean = 48.6; sd = 69.7; median = 25), and there was a positive correlation between the number events attended and number of substances used at the most recent event attended (p < 0.001). Analyses revealed that individuals reporting the use of ketamine, GHB, and/or cocaine at the most recent event had attended significantly more events than nonusers even when controlling for various demographic variables. A subset of respondents (n = 27) completed a second interview to determine the reliability of their responses. Results indicated that respondents could reliably recall details about which drugs were used, the total doses administered, as well as order of drug administration.
引用
收藏
页码:1525 / 1537
页数:13
相关论文
共 22 条
[1]  
[Anonymous], 1996, ALCOHOL TIMELINE FOL
[2]   Oral methylpherlidate-alcohol co-abuse [J].
Barrett, SP ;
Pihl, RO .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (06) :633-634
[3]   The timeline followback reports of psychoactive substance use by drug-abusing patients: Psychometric properties [J].
Fals-Stewart, W ;
O'Farrell, TJ ;
Freitas, TT ;
McFarlin, SK ;
Rutigliano, P .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2000, 68 (01) :134-144
[4]   A contextual profile of club drug use among adults in Chicago [J].
Fendrich, M ;
Wislar, JS ;
Johnson, TP ;
Hubbell, A .
ADDICTION, 2003, 98 (12) :1693-1703
[5]   The utility of drug testing in epidemiological research: results from a general population survey [J].
Fendrich, M ;
Johnson, TP ;
Wislar, JS ;
Hubbell', A ;
Spiehler, V .
ADDICTION, 2004, 99 (02) :197-208
[6]   Places and patterns of drug use in the Scottish dance scene [J].
Forsyth, AJM .
ADDICTION, 1996, 91 (04) :511-521
[7]   The effects and consequences of selected club drugs [J].
Freese, TE ;
Miotto, K ;
Reback, CJ .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2002, 23 (02) :151-156
[8]   Ecstasy and drug consumption patterns: A Canadian rave population study [J].
Gross, SR ;
Barrett, SP ;
Shestowsky, JS ;
Pihl, RO .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2002, 47 (06) :546-551
[9]   Pharmacokinetics and pharmacodynamics of cannabinoids [J].
Grotenhermen, F .
CLINICAL PHARMACOKINETICS, 2003, 42 (04) :327-360
[10]   3,4-methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans:: Psychomotor performance, subjective effects, and pharmacokinetics [J].
Hernández-López, C ;
Farré, M ;
Roset, PN ;
Menoyo, E ;
Pizarro, N ;
Ortuño, J ;
Torrens, M ;
Camí, J ;
De la Torre, R .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (01) :236-244